Delivery Order SPE2DB22D3301-SPE2DB25FY9BC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of chronic myeloid leukemia, reflecting the...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 29, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $6,007.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tasigna 150 mg capsules (28-count). The contract, which represents a non-competitive set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $18,023.70 to AmerisourceBergen Drug Corp for TASIGNA 150 MG capsules (28-count) on August 19, 2025. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,007.90 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tasigna 150 mg capsules (28-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The contract will be completed by September 2, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of October 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tasigna 150 mg capsules (28-count units) with a ceiling value of $6,007.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement under the company's existing...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9BCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. This non-competitive delivery order, issued on August 8, 2025, with an ultimate completion date of August 29, 2025, will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tasigna is a specialized oncology medication used in the treatment of certain types of leukemia, reflecting the critical pharmaceutical supply needs of the Department of Defense and military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with DLA and routinely fulfills competitively awarded orders for brand-name and generic medications, vaccines, and specialized medical supplies supporting military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/8/25 |